Trexquant Investment’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14,397	Closed	-$314K	–	1882
2023 Q3	$314K	Buy	+14,397	New	+$314K	0.01%	1204
2022 Q1	–	Sell	-10,727	Closed	-$348K	–	1819
2021 Q4	$348K	Sell	10,727 -17,474	-62%	-$567K	0.02%	843
2021 Q3	$832K	Buy	+28,201	New	+$832K	0.07%	372